Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 47.98% is 20% below its 5-year average of 59.98%, around the middle of its 5-year range (-42.08%–100.28%).
31.73% above its 12-month average of 36.42%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 95.17%.
EBITDA MARGIN
47.98%
EBITDA MARGIN AVG TTM
36.42%
EBITDA MARGIN AVG 3Y
47.62%
EBITDA MARGIN AVG 5Y
59.98%
EBITDA MARGIN AVG 10Y
77.84%
EBITDA MARGIN AVG 15Y
70.79%
EBITDA MARGIN AVG 20Y
-140.31%
CURRENT VS TTM AVG
+31.73%
CURRENT VS 3Y AVG
+0.75%
CURRENT VS 5Y AVG
-20.01%
CURRENT VS 10Y AVG
-38.36%
CURRENT VS 15Y AVG
-32.22%
CURRENT VS 20Y AVG
+134.20%
Market Cap
$1.54B
EBITDA Margin
33.84%
TTM Avg
32.51%
3Y Avg
-30.03%
5Y Avg
-1.40%
Market Cap
$1.54B
EBITDA Margin
-1075.09%
TTM Avg
-854.02%
3Y Avg
-886.21%
5Y Avg
-631.69%
Market Cap
$1.51B
EBITDA Margin
5.15%
TTM Avg
0.72%
3Y Avg
-7.50%
5Y Avg
-11313.48%
Market Cap
$1.50B
EBITDA Margin
16.46%
TTM Avg
14.25%
3Y Avg
12.03%
5Y Avg
12.13%
Market Cap
$1.49B
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Innoviva, Inc. (INVA) | $1.54B | 47.98% | 36.42% | 47.62% | 59.98% |
| Nutex Health, Inc. (NUTX)vs › | $1.54B | 33.84% | 32.51% | -30.03% | -1.40% |
| uniQure N.V. (QURE)vs › | $1.54B | -1075.09% | -854.02% | -886.21% | -631.69% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.51B | 5.15% | 0.72% | -7.50% | -11313.48% |
| Phibro Animal Health Corporation (PAHC)vs › | $1.50B | 16.46% | 14.25% | 12.03% | 12.13% |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.49B | N/A | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.49B | N/A | N/A | N/A | N/A |
| Omnicell, Inc. (OMCL)vs › | $1.60B | 8.30% | 8.20% | 7.63% | 9.66% |
| Certara, Inc. (CERT)vs › | $1.48B | 18.52% | 17.87% | 16.34% | 15.57% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.48B | N/A | N/A | N/A | N/A |
Gross Margin
73.1%
EBITDA Margin
48.0%
Operating Margin
36.7%
Net Margin
80.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 95.17% |
| 2026-03-31 | 49.18% |
| 2025-12-31 | 41.60% |
| 2025-09-30 | 38.24% |
| 2025-06-30 | -42.08% |
| 2025-03-31 | -39.44% |
| 2024-12-31 | 54.08% |
| 2024-09-30 | 62.85% |
| 2024-06-30 | 62.51% |
| 2024-03-31 | 41.61% |
| 2023-12-31 | 51.30% |
| 2023-09-30 | 45.88% |
| 2023-06-30 | 28.98% |
| 2023-03-31 | 32.66% |
| 2022-12-31 | 53.11% |
| 2022-09-30 | 20.41% |
| 2022-06-30 | 79.60% |
| 2022-03-31 | 86.31% |
| 2021-12-31 | 100.28% |
| 2021-09-30 | 100.15% |
| 2021-06-30 | 95.77% |
| 2021-03-31 | 92.95% |
| 2020-12-31 | 93.72% |
| 2020-09-30 | 99.09% |
| 2020-06-30 | 100.38% |
| 2020-03-31 | 101.14% |
| 2019-12-31 | 101.50% |
| 2019-09-30 | 97.50% |
| 2019-06-30 | 98.74% |
| 2019-03-31 | 100.95% |
| 2018-12-31 | 101.04% |
| 2018-09-30 | 99.11% |
| 2018-06-30 | 98.59% |
| 2018-03-31 | 84.31% |
| 2017-12-31 | 100.55% |
| 2017-09-30 | 89.46% |
| 2017-06-30 | 87.64% |
| 2017-03-31 | 81.10% |
| 2016-12-31 | 94.37% |
| 2016-09-30 | 94.30% |
| 2016-06-30 | 79.78% |
| 2016-03-31 | 86.93% |
| 2015-12-31 | 90.98% |
| 2015-09-30 | 87.87% |
| 2015-06-30 | 48.19% |
| 2015-03-31 | 11.19% |
| 2014-12-31 | 49.24% |
| 2014-09-30 | -701.90% |
| 2014-06-30 | -749.89% |
| 2014-03-31 | -8403.03% |
| 2013-12-31 | -468.42% |
| 2013-09-30 | -1346.92% |
| 2013-06-30 | -509.42% |
| 2013-03-31 | -2342.93% |
| 2012-12-31 | -484.93% |
| 2012-09-30 | -2200.00% |
| 2012-06-30 | -2380.91% |
| 2012-03-31 | 69.20% |
| 2011-12-31 | -623.85% |
| 2011-09-30 | -422.17% |
| 2011-06-30 | -342.78% |
| 2011-03-31 | -310.41% |
| 2010-12-31 | -234.72% |
| 2010-09-30 | -344.87% |
| 2010-06-30 | -284.32% |
| 2010-03-31 | -342.98% |
| 2009-12-31 | -468.84% |
| 2009-09-30 | -355.10% |
| 2009-06-30 | -364.63% |
| 2009-03-31 | -179.62% |
| 2008-12-31 | -148.60% |
| 2008-09-30 | -317.25% |
| 2008-06-30 | -444.90% |
| 2008-03-31 | -504.20% |
| 2007-12-31 | -573.94% |
| 2007-09-30 | -598.39% |
| 2007-06-30 | -883.77% |
| 2007-03-31 | -951.96% |
| 2006-12-31 | -813.67% |
| 2006-09-30 | -731.35% |
| 2006-06-30 | -904.53% |
| 2006-03-31 | -1180.31% |
| 2005-12-31 | -1269.89% |
| 2005-09-30 | -1275.52% |
| 2005-06-30 | -1106.08% |
| 2005-03-31 | -1160.32% |
| 2004-12-31 | -970.66% |
| 2004-09-30 | -839.06% |
| 2004-06-30 | -1747.03% |
